BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
11/6/2020 9:07:37 AM | Browse: 714 | Download: 1778
 |
Received |
|
2020-05-28 07:45 |
|
Peer-Review Started |
|
2020-05-28 07:45 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2020-08-25 11:55 |
|
Revised |
|
2020-09-11 15:13 |
|
Second Decision |
|
2020-09-22 09:13 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2020-09-22 20:23 |
|
Articles in Press |
|
2020-09-22 20:23 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2020-11-03 00:33 |
|
Publish the Manuscript Online |
|
2020-11-06 09:07 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Asad Izziddin Dajani and Branko Popovic |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Branko Popovic, MD, N/A, N/A, Sanofi-Aventis Deutschland GmbH, CHC Global Medical Affairs, Industriepark Höchst, Frankfurt am Main 65926, Germany. branko.popovic@sanofi.com |
| Key Words |
Non-alcoholic fatty liver disease; Diabetes; Obesity; Metabolic syndrome; Essential phospholipids; Systematic review |
| Core Tip |
Essential phospholipids (EPL) are used for the supportive treatment of non-alcoholic fatty liver disease, but the data are mostly from small-scale studies. Thus, we used meta-analytical techniques to assess the efficacy of EPL in patients with non-alcoholic fatty liver disease and type 2 diabetes and/or obesity. Our results indicate EPL provides benefit in this patient population, reducing alanine aminotransferase, triglyceride and cholesterol levels, and improving disease severity (as measured by ultrasonography). Larger-scale trials are warranted to confirm these findings. |
| Publish Date |
2020-11-06 09:07 |
| Citation |
Dajani AI, Popovic B. Essential phospholipids for nonalcoholic fatty liver disease associated with metabolic syndrome: A systematic review and network meta-analysis. World J Clin Cases 2020; 8(21): 5235-5249 |
| URL |
https://www.wjgnet.com/2307-8960/full/v8/i21/5235.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v8.i21.5235 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
